Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis. Wood H, Chandler A, Nezamololama N, Papp K, et al. Int J Dermatol 2021 Aug 22. doi: 10.1111/ijd.15853.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wood H, Chandler A, Nezamololama N, Papp K, et al. Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis. Int J Dermatol 2021 Aug 22. doi: 10.1111/ijd.15853.
PMID: 34423443